oh dear
For the quarter ended March 31, 2024, AVITA Medical now expects commercial revenue to be in the range of US$11.0 million to US$11.3 million. This range is below the previously provided revenue guidance of US$14.8 million to US$15.6 million. The revision in guidance is attributable to a slower-than-expected conversion rate of new accounts for our expanded label of full-thickness skin defects.
oh dearFor the quarter ended March 31, 2024, AVITA Medical now...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.71 |
Change
-0.250(8.45%) |
Mkt cap ! $168.5M | |||
| Open | High | Low | Value | Volume |
| $2.78 | $2.83 | $2.71 | $2.015M | 728.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3071 | $2.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.73 | 1874 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.72 |
Change
-0.250 ( 8.30 %) |
||||
| Open | High | Low | Volume | ||
| $2.79 | $2.83 | $2.71 | 12865 | ||
| Last updated 15.57pm 09/05/2024 ? | |||||
| AVH (ASX) Chart |